151 related articles for article (PubMed ID: 35925389)
1. Molecular subtyping of gastroesophageal dysplasia heterogeneity according to TCGA/ACRG classes.
Angerilli V; Pennelli G; Galuppini F; Realdon S; Fantin A; Savarino E; Farinati F; Mastracci L; Luchini C; Fassan M
Virchows Arch; 2022 Oct; 481(4):545-552. PubMed ID: 35925389
[TBL] [Abstract][Full Text] [Related]
2. Reproduction of the Cancer Genome Atlas (TCGA) and Asian Cancer Research Group (ACRG) Gastric Cancer Molecular Classifications and Their Association with Clinicopathological Characteristics and Overall Survival in Moroccan Patients.
Nshizirungu JP; Bennis S; Mellouki I; Sekal M; Benajah DA; Lahmidani N; El Bouhaddouti H; Ibn Majdoub K; Ibrahimi SA; Celeiro SP; Viana-Pereira M; Munari FF; Ribeiro GG; Duval V; Santana I; Reis RM
Dis Markers; 2021; 2021():9980410. PubMed ID: 34367379
[TBL] [Abstract][Full Text] [Related]
3. Molecular subtyping of gastric cancer according to ACRG using immunohistochemistry - Correlation with clinical parameters.
Pretzsch E; Bösch F; Todorova R; Nieß H; Jacob S; Guba M; Kirchner T; Werner J; Klauschen F; Angele MK; Neumann J
Pathol Res Pract; 2022 Mar; 231():153797. PubMed ID: 35151032
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and prognostic significance of TCGA and ACRG classification in gastric cancer among the Chinese population.
Wang Q; Xie Q; Liu Y; Guo H; Ren Y; Li J; Zhao Q
Mol Med Rep; 2020 Aug; 22(2):828-840. PubMed ID: 32468041
[TBL] [Abstract][Full Text] [Related]
5. Gastric cancer molecular classification based on immunohistochemistry and in situ hybridization: Analysis in western patients after curative-intent surgery.
Ramos MFKP; Pereira MA; de Mello ES; Cirqueira CDS; Zilberstein B; Alves VAF; Ribeiro-Junior U; Cecconello I
World J Clin Oncol; 2021 Aug; 12(8):688-701. PubMed ID: 34513602
[TBL] [Abstract][Full Text] [Related]
6. Histo- and immunohistochemistry-based estimation of the TCGA and ACRG molecular subtypes for gastric carcinoma and their prognostic significance: A single-institution study.
Yoon JY; Sy K; Brezden-Masley C; Streutker CJ
PLoS One; 2019; 14(12):e0224812. PubMed ID: 31790410
[TBL] [Abstract][Full Text] [Related]
7. Molecular classification of esophagogastric junction carcinoma correlated with prognosis.
Zou L; Wu Y; Ma K; Fan Y; Dong D; Geng N; Li E
Onco Targets Ther; 2017; 10():4765-4772. PubMed ID: 29026322
[TBL] [Abstract][Full Text] [Related]
8. Gastric hepatoid adenocarcinomas are a genetically heterogenous group; most tumors show chromosomal instability, but MSI tumors do exist.
Tsuruta S; Ohishi Y; Fujiwara M; Ihara E; Ogawa Y; Oki E; Nakamura M; Oda Y
Hum Pathol; 2019 Jun; 88():27-38. PubMed ID: 30946937
[TBL] [Abstract][Full Text] [Related]
9. Prognostic importance of molecular-like classification in gastroesophageal junction tumors (Izmir Oncology Group [IZOG] study).
Özdemir Ö; Argon A; Yakan S; Salman T; AlacacIoğlu A
Pol J Pathol; 2021; 72(4):315-323. PubMed ID: 35308002
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry as a surrogate for molecular subtyping of gastric adenocarcinoma.
Gonzalez RS; Messing S; Tu X; McMahon LA; Whitney-Miller CL
Hum Pathol; 2016 Oct; 56():16-21. PubMed ID: 27342907
[TBL] [Abstract][Full Text] [Related]
11. Molecular subtyping of gastric cancer with respect to the growth pattern of lymph-node metastases.
Bösch F; Todorova R; Link H; Westphalen CB; Boeck S; Heinemann V; Werner J; Kirchner T; Angele MK; Neumann J
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2689-2697. PubMed ID: 31541339
[TBL] [Abstract][Full Text] [Related]
12. PD-L1 expression in gastroesophageal dysplastic lesions.
Fassan M; Brignola S; Pennelli G; Alberti G; Angerilli V; Bressan A; Pellino A; Lanza C; Salmaso R; Lonardi S; Pucciarelli S; Spolverato G; Scarpa M; Realdon S; Farinati F; Luchini C; Rugge M; Loupakis F
Virchows Arch; 2020 Jul; 477(1):151-156. PubMed ID: 31724072
[TBL] [Abstract][Full Text] [Related]
13. Expression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and p53 tumor suppressor in dysplastic progression and adenocarcinoma in Barrett esophagus.
Hanas JS; Lerner MR; Lightfoot SA; Raczkowski C; Kastens DJ; Brackett DJ; Postier RG
Cancer; 1999 Sep; 86(5):756-63. PubMed ID: 10463972
[TBL] [Abstract][Full Text] [Related]
14. A case of gastric cancer with heterogeneous components of EB virus (+)/TP53 (+) and EB virus (-)/TP53 (-).
Matsuda I; Kan K; Doi S; Motoki Y; Onodera M; Hirota S
Int J Clin Exp Pathol; 2015; 8(9):11766-71. PubMed ID: 26617924
[TBL] [Abstract][Full Text] [Related]
15. High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features.
Liu X; Choi MG; Kim K; Kim KM; Kim ST; Park SH; Cristescu R; Peter S; Lee J
Pathol Res Pract; 2020 Apr; 216(4):152881. PubMed ID: 32089413
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus associated gastric dysplasia: a new rare entity?
Angerilli V; Galuppini F; Pennelli G; Fanelli GN; d'Amore ESG; Michelotto M; Pilati P; Spolverato G; Pucciarelli S; Scarpa M; Farinati F; Savarino E; Realdon S; Lonardi S; Bergamo F; Loupakis F; Dei Tos AP; Vanoli A; Fassan M
Virchows Arch; 2022 Apr; 480(4):939-944. PubMed ID: 34537878
[TBL] [Abstract][Full Text] [Related]
17. MLH1, BRAF and p53 - searching for significant markers to predict evolution towards adenocarcinoma in colonic sessile serrated lesions.
Răduţă D; Dincă OM; Micu GV; Nichita L; Cioplea MD; Buşcă RM; Ardeleanu R; Mateescu RB; Benguş A; Zurac SA; Popp CG; Vlădan GC
Rom J Morphol Embryol; 2021; 62(4):971-979. PubMed ID: 35673816
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite instability and Epstein-Barr virus combined with PD-L1 could serve as a potential strategy for predicting the prognosis and efficacy of postoperative chemotherapy in gastric cancer.
Yang N; Wu Y; Jin M; Jia Z; Wang Y; Cao D; Qin L; Wang X; Zheng M; Cao X; Jiang J
PeerJ; 2021; 9():e11481. PubMed ID: 34046266
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological characteristics of Epstein-Barr virus and microsatellite instability subtypes of early gastric neoplasms classified by the Japanese and the World Health Organization criteria.
Tanabe H; Mizukami Y; Takei H; Tamamura N; Omura Y; Kobayashi Y; Murakami Y; Kunogi T; Sasaki T; Takahashi K; Ando K; Ueno N; Kashima S; Yuzawa S; Hasegawa K; Sumi Y; Tanino M; Fujiya M; Okumura T
J Pathol Clin Res; 2021 Jul; 7(4):397-409. PubMed ID: 33750036
[TBL] [Abstract][Full Text] [Related]
20. Immunogenic characteristics of microsatellite instability-low esophagogastric junction adenocarcinoma based on clinicopathological, molecular, immunological and survival analyses.
Imamura Y; Toihata T; Haraguchi I; Ogata Y; Takamatsu M; Kuchiba A; Tanaka N; Gotoh O; Mori S; Nakashima Y; Oki E; Mori M; Oda Y; Taguchi K; Yamamoto M; Morita M; Yoshida N; Baba H; Mine S; Nunobe S; Sano T; Noda T; Watanabe M
Int J Cancer; 2021 Mar; 148(5):1260-1275. PubMed ID: 32997798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
